Artwork

Content provided by Barry Singer, MD, Barry Singer, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Barry Singer, MD, Barry Singer, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Inside MS: Navigating Inflammation

38:02
 
Share
 

Manage episode 371028312 series 2869252
Content provided by Barry Singer, MD, Barry Singer, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Barry Singer, MD, Barry Singer, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dive into a deeper understanding of the role of inflammation in causing injury to the brain and spinal cord in multiple sclerosis. It’s a journey marked by ups and downs, where the adaptive immune system composed of lymphocytes (T and B cells) attack myelin and the innate immune system clears damaged myelin. An immune cell called microglia can create smoldering inflammation in MS that poses a threat of progressive disability.

Explore the arsenal of MS treatment strategies developed over the past 3 decades to either alter or suppress the immune system to reduce inflammation. Triumphs and limitations of our current MS therapies shared. Antioxidant research, diet and new therapeutics tackling smoldering inflammation bring newfound hope.

Barry Singer MD, Director of The MS Center for Innovations in Care, interviews:

Klaus Schemierer MB BS, PhD, FRCP, Professor of Neurology at the Blizard Institute, Queen Mary University of London, and Consultant Neurologist at The Royal London Hospital, Barts Health NHS Trust.

Michael Kornberg MD, PhD, Assistant Professor of Neurology at John Hopkins.

  continue reading

42 episodes

Artwork
iconShare
 
Manage episode 371028312 series 2869252
Content provided by Barry Singer, MD, Barry Singer, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Barry Singer, MD, Barry Singer, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dive into a deeper understanding of the role of inflammation in causing injury to the brain and spinal cord in multiple sclerosis. It’s a journey marked by ups and downs, where the adaptive immune system composed of lymphocytes (T and B cells) attack myelin and the innate immune system clears damaged myelin. An immune cell called microglia can create smoldering inflammation in MS that poses a threat of progressive disability.

Explore the arsenal of MS treatment strategies developed over the past 3 decades to either alter or suppress the immune system to reduce inflammation. Triumphs and limitations of our current MS therapies shared. Antioxidant research, diet and new therapeutics tackling smoldering inflammation bring newfound hope.

Barry Singer MD, Director of The MS Center for Innovations in Care, interviews:

Klaus Schemierer MB BS, PhD, FRCP, Professor of Neurology at the Blizard Institute, Queen Mary University of London, and Consultant Neurologist at The Royal London Hospital, Barts Health NHS Trust.

Michael Kornberg MD, PhD, Assistant Professor of Neurology at John Hopkins.

  continue reading

42 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide